All Stories

  1. The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan

    Article • PLoS ONE, January 2021, PLOS

    Dr Jee-Fu Huang

  2. Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B

    Article • Expert Opinion on Drug Metabolism & Toxicology, October 2019, Taylor & Francis

    Dr Jee-Fu Huang, Professor MING-LUNG YU

  3. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients

    Article • PLoS ONE, August 2019, PLOS

    Dr Jee-Fu Huang

  4. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication

    Article • Journal of Gastroenterology and Hepatology, July 2018, Wiley

    Professor MING-LUNG YU, Dr Jee-Fu Huang

  5. Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy

    Article • Journal of Gastroenterology and Hepatology, February 2018, Wiley

    Professor MING-LUNG YU, Dr Jee-Fu Huang

  6. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma

    Article • Liver International, November 2017, Wiley

    Professor MING-LUNG YU, Dr Jee-Fu Huang

  7. The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients

    Article • Journal of Gastroenterology and Hepatology, November 2015, Wiley

    Dr Jee-Fu Huang